Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

AMD Plunges, But Here's Why The Pullback Could Offer Opportunity

Advanced Micro Devices (NASDAQ: AMD) was plunging 8% on Thursday, negating the uptrend the stock began trading in on March 8 when it bounced off the $100 level.

Sorrento To Start Late-Stage Trial Of Abivertinib In Critically-Ill COVID-19 Patients

Sorrento To Start Late-Stage Trial Of Abivertinib In Critically-Ill COVID-19 Patients

The FDA has signed off Sorrento Therapeutics Inc's (NASDAQ:SRNE) Phase 3 trial of abivertinib in severe COVID-19 patients. The clinical trial will be conducted in 2 phases, and the initial run-in will define the recommended Phase 3 Dose. In October last year, Sorrento released preliminary results of two phase 2 studies that seemed to show…

12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session

12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Xometry Receives ISO Certification For Medical Device Manufacturing

Xometry Inc (NASDAQ:XMTR) has obtained ISO 13485 certification, allowing it to expand the range of medical device manufacturing in the Xometry marketplace. The company notes the certification broadens its footprint in the medical industry. Xometry currently works with 86% of Fortune 500 medical product and equipment companies, providing prototyping and manufacturing support.…

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Industrials Stocks Moving In Thursday's Intraday Session

12 Information Technology Stocks Moving In Thursday's Intraday Session

inkl

Read news from The Economist, FT, and more,
with one subscription

Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday

On Thursday, 92 companies hit new 52-week lows.

Recap: Trevena Q4 Earnings

Recap: Trevena Q4 Earnings

Trevena (NASDAQ:TRVN) reported its Q4 earnings results on Thursday, March 31, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

36 Stocks Moving In Thursday's Mid-Day Session

36 Stocks Moving In Thursday's Mid-Day Session

Inspirato Incorporated Stock Remains Volatile: What's Going On?

Inspirato Incorporated Stock Remains Volatile: What's Going On?

Inspirato Incorporated (NASDAQ: ISPO) shares are trading higher on above-average volume Thursday.

Tesla Pausing Solar Roof Installations; Supply Chain Issues Could Have Some Customers Rained On

Tesla Pausing Solar Roof Installations; Supply Chain Issues Could Have Some Customers Rained On

Tesla Inc (NASDAQ: TSLA) has faced supply chain challenges for its automotive division and is now pausing a separate division.

Dynatrace Expands Partnership With Amazon Web Services

Dynatrace Expands Partnership With Amazon Web Services

Dynatrace Inc (NYSE:DT) has expanded its partnership with Amazon.Com Inc's (NASDAQ:AMZN) Amazon Web Services Inc (AWS). Under the partnership, Dynatrace will work with AWS to align on new product and solution development. The initiative will provide organizations worldwide with easier access to the Dynatrace Software Intelligence Platform through the AWS Marketplace. Under the existing collaboration, the…

Why Nvidia Stock Could Surpass $300 On A Break From This Pattern

Why Nvidia Stock Could Surpass $300 On A Break From This Pattern

NVIDIA Corporation (NASDAQ: NVDA) was trading near flat Thursday, in another period of consolidation where the stock shot up over 33% between March 15 and Tuesday.

Get all your
news in one place.

100's of premium titles.
One news app.

10 Communication Services Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

10 Information Technology Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

If You Invested $100 In Analog Devices 5 Years Ago, Here's How Much You Would Have Today

Analog Devices (NASDAQ:ADI) has outperformed the market over the past 5 years by 1.26% on an annualized basis producing an average annual return of 15.41%. Currently, Analog Devices has a market capitalization of $87.03 billion.

$1000 Invested In Intuitive Surgical 10 Years Ago Would Be Worth This Much

Intuitive Surgical (NASDAQ:ISRG) has outperformed the market over the past 10 years by 5.03% on an annualized basis producing an average annual return of 17.59%. Currently, Intuitive Surgical has a market capitalization of $109.71 billion.

Get all your
news in one place.

100's of premium titles.
One news app.

All The Stocks That Moved From Thursday's CNBC's 'Fast Money: Halftime Report'

CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.

Taysha Gene Therapies Lays Off 35% Of staff, Narrows R&D Focus

Taysha Gene Therapies Inc (NASDAQ: TSHA) is the latest company to slim down by

Why Bitcoin-, Ethereum- And Litecoin-Related Stocks Are Falling

Shares of crypto-related stocks, including Bitfarms Ltd (NASDAQ: BITF), Coinbase Global Inc (NASDAQ: COIN) and Riot Blockchain Inc (NASDAQ:

Eloxx to Test Its Lead Product Candidate, ELX-02, In Rare Kidney Disease

Eloxx Pharmaceuticals Inc (NASDAQ: ELOX)

NRx Pharma Says I-SPY Study Of Inhaled Zyesami In Critical COVID-19 Stopped

Quantum Leap Healthcare Collaborative (QLHC) announced that the nebulized form of NRx Pharmaceuticals Inc's (NASDAQ: NRXP) Zyesami (Aviptadil) in the I-SPY COVID Trial of

InflaRx Shares Plunge After Disappointing Results On Vilobelimab In Critically Ill COVID-19 Patients

InflaRx N.V. (NASDAQ:IFRX) announced topline data from Phase 3 part of Phase 2/3 PANAMO study of vilobelimab in critically ill COVID-19 patients. Vilobelimab in mechanically ventilated COVID-19 patients showed a relative reduction in 28-day all-cause mortality of 23.9% (vilobelimab 31.7% versus placebo 41.6%), which was not statistically significant (p=0.094). At the recommendation of…

Supply Chain Challenges To Hit Masimo's Q1 FY22 Sales

Masimo Corp (NASDAQ:MASI) expects Q1 FY22 product revenue of $285 million - $315 million, lower than expected. Shortages of critical components and other supply chain issues, including freight carrier delays, have led to lower-than-expected sales in the first quarter. Related: Joe Kiani, Chairman, and CEO, said, "In prior quarters, we were able…

1 … 748 749 750 751

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Advanced Micro Devices

NVIDIA Corporation

Coinbase Global Inc

Intuitive Surgical

Motorsport Games

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play